Our eleventh webinar in our Cell & Gene Therapy series entitled Destination BLA, First Stop IND! Considerations for Designing Your Gene Therapy Preclinical and CMC development strategies – takes place on June 14 at 11.00am ET/4.00pm GMT.

Come and join us as we discuss the multiple considerations to be taken into account when designing your gene therapy preclinical and CMC development strategies to ensure successful IND submission to allow first patient dosing. Our expert panel Ashley Winslow, Vibhor Gupta, Ph.D. and Linda Randall will share their experiences to help build successful strategies that carefully balance time and cost whilst always ensuring qualit

Our presenters:

> Key Option Leader: Ashley Winslow PhD, President & Chief Scientific Officer, Odylia Therapeutics
> Vibhor Gupta, PhD, Director – CGT Business Operations at Pharmaron
> Linda Randall PhD, Associate Vice President, Biologics Development, Manufacturing and Control at Pharmaron Gene Therapy

By registering once, you will have access to and receive updates for each webinar in the series.

For further information on our CGT webinar series including previous on demand recordings please visit https://www.pharmaron.com/cgt-webinar